Evidence map›Paper›PMID 40711243›Full record

ArticleNanomaterials (Basel, Switzerland)2025

An Ultra-Narrowband Graphene-Perfect Absorber Based on Bound States in the Continuum of All-Dielectric Metasurfaces.

Qi Zhang, Xiao Zhang, Zhihong Zhu, Chucai Guo

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Qi ZhangCollege of Advanced Interdisciplinary Studies & Hunan Provincial Key Laboratory of Novel-Optoelectronic Information Materials and Devices, National University of Defense Technology, Changsha 410073, China.
Xiao ZhangCollege of Advanced Interdisciplinary Studies & Hunan Provincial Key Laboratory of Novel-Optoelectronic Information Materials and Devices, National University of Defense Technology, Changsha 410073, China.
Zhihong ZhuCollege of Advanced Interdisciplinary Studies & Hunan Provincial Key Laboratory of Novel-Optoelectronic Information Materials and Devices, National University of Defense Technology, Changsha 410073, China.
Chucai GuoCollege of Advanced Interdisciplinary Studies & Hunan Provincial Key Laboratory of Novel-Optoelectronic Information Materials and Devices, National University of Defense Technology, Changsha 410073, China.ORCID 0000-0002-8283-306X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Enhancing light absorption in two-dimensional (2D) materials, particularly few-layer structures, is critical for advancing optoelectronic devices such as light sources, photodetectors, and sensors. However, conventional absorption enhancement strategies often suffer from unstable resonant wavelengths and low-quality factors (Q-factors) due to the inherent weak light-matter interactions in 2D materials. To address these limitations, we propose an all-dielectric metasurface graphene-perfect absorber based on toroidal dipole bound state in the continuum (TD-BIC) with an ultra-narrow bandwidth and stable resonant wavelength. The proposed structure achieves tunable absorption linewidths spanning three orders of magnitude (6 nm to 0.0076 nm) through critical coupling modulation. Furthermore, the operational wavelength can be flexibly extended to any near-infrared region by adjusting the grating width. This work establishes a novel paradigm for enhancing the absorption of 2D materials in photonic device applications.

Indexed as

grapheneperfect absorptionultra-narrowband

Identifiers

PMID40711243
PMCPMC12300899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.